Fundalysisby DARKHORSESTOCKS

Stock · US75886F1075

Regeneron Pharmaceuticals

Held by 3 schemes worth ₹63.3 Cr in Sept 2026.

Schemes holding Regeneron Pharmaceuticals(Dec 2012 – Sept 2026)

Schemes holding Regeneron Pharmaceuticals in Sept 2026. Tick up to 2 to plot them.
Plot3 schemes · ₹ Cr
Motilal Oswal Nasdaq 100 ETF
46.2
ICICI Prudential Nasdaq 100 Index Fund
12
Motilal Oswal S&P 500 Index Fund
5.1
  • Motilal Oswal Nasdaq 100 ETF
  • ICICI Prudential Nasdaq 100…
Market value of Regeneron Pharmaceuticals in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
MonthMotilal Oswal Nasdaq 100 ETFICICI Prudential Nasdaq 100 Index Fund
Sept 2025₹33.9 Cr₹8 Cr
Oct 2025₹39.3 Cr₹9.3 Cr
Nov 2025₹47.5 Cr₹11.1 Cr
Dec 2025₹49.2 Cr₹11.5 Cr
Jan 2026₹47 Cr₹11.1 Cr
Feb 2026₹48.8 Cr₹12.1 Cr
Mar 2026₹49.8 Cr₹12.6 Cr
Apr 2026₹45.8 Cr₹11.6 Cr
May 2026₹39.7 Cr₹10.2 Cr
Jun 2026₹39.3 Cr₹10.1 Cr
Jul 2026₹48.7 Cr₹12.3 Cr
Aug 2026₹50.1 Cr₹13 Cr
Sept 2026₹46.2 Cr₹12 Cr
Fig. 1.Market value of Regeneron Pharmaceuticals in each ticked scheme, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation(Sept 2026)

Fund houses

2 fund houses% of total
Motilal Oswal
281.03
ICICI
118.97

Scheme types

Schemes

Fig. 2.What mutual funds hold of this company, by fund house, by scheme type and by scheme. Hover a slice or a row; click a slice to open it.

Schemes buying and selling Regeneron Pharmaceuticals(Oct 2025 – Sept 2026)

Schemes buying and selling Regeneron Pharmaceuticals. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.